Truist raised the firm’s price target on Amentum (AMTM) to $34 from $30 and keeps a Buy rating on the shares. The firm is citing the company’s faster long-term organic growth outlook translating into a higher target multiple, the analyst tells investors in a research note. Truist further notes that the macro commercial tailwinds in nuclear and data centers and the government focus on space and missile defense is among the positive catalysts for the stock.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMTM:
- Amentum price target raised to $34 from $30 at JPMorgan
- Amentum price target raised to $35 from $30 at Citizens JMP
- Amentum Holdings, Inc.: Upgraded to Hold Amid Strong Nuclear Sector Prospects and Improved Risk-Reward Profile
- Amentum upgraded to Equal Weight from Underweight at Morgan Stanley
- Amentum Holdings Reports Robust Fiscal Year 2025 Results
